Altimmune, Inc.ALTNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank79
5Y CAGR-14.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-14.9%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$14.99M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$33.51M-
2019$0.00-100.0%
2018$18.46M+0.3%
2017$18.41M+154.9%
2016$7.22M-